Chemoinformaics analysis of 2-methyl-1,3,6-trihydroxy-9,10-anthraquinone
| Molecular Weight | 620.56 | nRot | 6 |
| Heavy Atom Molecular Weight | 588.304 | nRig | 31 |
| Exact Molecular Weight | 620.174 | nRing | 5 |
| Solubility: LogS | -3.581 | nHRing | 2 |
| Solubility: LogP | 0.998 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 76 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 12 |
| nHA | 15 | APOL | 81.7974 |
| nHD | 7 | BPOL | 43.3866 |
| QED | 0.16 |
| Synth | 4.759 |
| Natural Product Likeliness | 2.115 |
| NR-PPAR-gamma | 0.841 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.367 |
| Pgp-sub | 0.995 |
| HIA | 0.969 |
| CACO-2 | -6.266 |
| MDCK | 0.0000552 |
| BBB | 0.115 |
| PPB | 0.820378 |
| VDSS | 0.504 |
| FU | 0.133314 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.026 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.103 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.127 |
| CYP3a4-inh | 0.03 |
| CYP3a4-sub | 0.07 |
| CL | 1.995 |
| T12 | 0.162 |
| hERG | 0.011 |
| Ames | 0.847 |
| ROA | 0.042 |
| SkinSen | 0.01 |
| Carcinogencity | 0.815 |
| EI | 0.011 |
| Respiratory | 0.007 |
| NR-Aromatase | 0.784 |
| Antiviral | Yes |
| Prediction | 0.851188 |